Kestra Private Wealth Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Kestra Private Wealth Services's DGX Position: Q2 2026 in Review
Kestra Private Wealth Services increased its Quest Diagnostics (DGX) stake by 19% in Q2 2026, buying an estimated $214K and bringing the position to 6,940 shares worth $1.47M. The position accounts for 0.02% of the portfolio, ranked #709.
Kestra Private Wealth Services first reported a position in DGX in Q2 2021 and has held it in 12 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Kestra Private Wealth Services held 6,940 shares of Quest Diagnostics worth $1.47M as of Q2 2026.
- Kestra Private Wealth Services bought 1,092 Quest Diagnostics shares in Q2 2026, an estimated $214K.
- Quest Diagnostics made up 0.02% of Kestra Private Wealth Services's portfolio in Q2 2026, its #709 holding.
- Kestra Private Wealth Services first reported a position in Quest Diagnostics in Q2 2021 and has held it in 12 quarters since.
- 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.